Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry W Hancock

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Gynecologic Oncology|December 13, 2023
PREDICT-GTN 2: Two-factor streamlined models match FIGO performance in gestational trophoblastic neoplasiaVictoria L Parker, Matthew C Winter, John A Tidy, et al.
The Journal of Reproductive Medicine|March 7, 2014
Management and survival of patients with FIGO high-risk gestational trophoblastic neoplasia: the U.K. experience, 1995-2010Roshan Agarwal, Costi Alifrangis, Janet Everard, et al.
Journal of the National Cancer Institute|February 8, 2007
Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort studyAnthony J Swerdlow, Craig D Higgins, Paul Smith, et al.
British Journal of Haematology|February 14, 2002
Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridizationJeannette E Allen, Rachael E Hough, John R Goepel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2006
Randomized phase II study comparing thalidomide with medroxyprogesterone acetate in patients with metastatic renal cell carcinomaChooi P Lee, Poulam M Patel, Peter J Selby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort studyAnthony J Swerdlow, Craig D Higgins, Paul Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519)Peter W M Johnson, John A Radford, Michael H Cullen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244Peter J Hoskin, Lisa Lowry, Alan Horwich, et al.
International Journal of Cancer|November 8, 2022
PREDICT-GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?Victoria L Parker, Matthew C Winter, John A Tidy, et al.
British Journal of Cancer|February 23, 2019
Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumoursFieke E M Froeling, Ramya Ramaswami, Panagiotis Papanastasopoulos, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|December 13, 2023
PREDICT-GTN 2: Two-factor streamlined models match FIGO performance in gestational trophoblastic neoplasiaVictoria L Parker, Matthew C Winter, John A Tidy, et al.
The Journal of Reproductive Medicine|March 7, 2014
Management and survival of patients with FIGO high-risk gestational trophoblastic neoplasia: the U.K. experience, 1995-2010Roshan Agarwal, Costi Alifrangis, Janet Everard, et al.
Journal of the National Cancer Institute|February 8, 2007
Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort studyAnthony J Swerdlow, Craig D Higgins, Paul Smith, et al.
British Journal of Haematology|February 14, 2002
Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridizationJeannette E Allen, Rachael E Hough, John R Goepel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2006
Randomized phase II study comparing thalidomide with medroxyprogesterone acetate in patients with metastatic renal cell carcinomaChooi P Lee, Poulam M Patel, Peter J Selby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort studyAnthony J Swerdlow, Craig D Higgins, Paul Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519)Peter W M Johnson, John A Radford, Michael H Cullen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244Peter J Hoskin, Lisa Lowry, Alan Horwich, et al.
International Journal of Cancer|November 8, 2022
PREDICT-GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?Victoria L Parker, Matthew C Winter, John A Tidy, et al.
British Journal of Cancer|February 23, 2019
Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumoursFieke E M Froeling, Ramya Ramaswami, Panagiotis Papanastasopoulos, et al.
Pageof 7